Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Dysfunction-associated Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06482112
What this trial is testing

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease+1 more
Merck Sharp & Dohme LLC 124
Not applicableLooking for participantsNCT07083336
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Who this might be right for
Type 2 Diabetes MellitusMetabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology 120
Post-approval studies (Phase 4)Enrolling By InvitationNCT06845345
What this trial is testing

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Who this might be right for
Diabetes Mellitus, Type 2Liver FibrosisLiver Steatoses+9 more
Carmen Dietvorst 70
Not applicableStudy completedNCT06352697
What this trial is testing

Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseSteatotic Liver DiseaseHepatic Steatosis
Bogomolets National Medical University 50
Not applicableNot Yet RecruitingNCT07475962
What this trial is testing

Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes

Who this might be right for
Type 1 DiabetesLiver SteatosesMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
Institut de Recherches Cliniques de Montreal 100
Early research (Phase 1)Looking for participantsNCT07358546
What this trial is testing

Efimosfermin Alfa in Adults With Hepatic Impairment

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 32
Large-scale testing (Phase 3)Study completedNCT06117137
What this trial is testing

The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus

Who this might be right for
Fatty Liver, Nonalcoholic
Sohag University 150
Not applicableEnrolling By InvitationNCT07312136
What this trial is testing

MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseCirrhosisAdvanced Fibrosis+6 more
Linkoeping University 317
Not applicableUnknownNCT06490432
What this trial is testing

Pattern of Cardiac Arrhythmia in Patients With MASLD

Who this might be right for
Cardiac ArrhythmiaMetabolic Dysfunction Associated Steatotic Liver Disease
Sohag University 100
Early research (Phase 1)Looking for participantsNCT07403604
What this trial is testing

Effect of Insulin Lowering on Lipogenesis

Who this might be right for
HyperinsulinemiaInsulin ResistanceNon-Alcoholic Fatty Liver Disease+2 more
Columbia University 25
Not applicableLooking for participantsNCT07682363
What this trial is testing

Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians

Who this might be right for
Liver Disease
Novo Nordisk A/S 470
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07495995
What this trial is testing

SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Cedars-Sinai Medical Center 94
Early research (Phase 1)Not Yet RecruitingNCT06558422
What this trial is testing

Human Models of Selective Insulin Resistance: Pancreatic Clamp

Who this might be right for
Insulin ResistanceHyperinsulinemiaMetabolic Dysfunction Associated Steatotic Liver Disease+3 more
Columbia University 36
Not applicableStudy completedNCT06647095
What this trial is testing

New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
HealthySimple Steatosis (SS)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
General University Hospital, Prague 172
Not applicableNot Yet RecruitingNCT07764835
What this trial is testing

Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis B+2 more
D'Or Institute for Research and Education 300
Not applicableLooking for participantsNCT06585982
What this trial is testing

Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis

Who this might be right for
Fatty Liver Disease
Universitas Diponegoro 50
Testing effectiveness (Phase 2)Looking for participantsNCT06935994
What this trial is testing

Aspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver Disease
Taichung Veterans General Hospital 120
Not applicableLooking for participantsNCT06867419
What this trial is testing

Metabolic Features Effects on FAST Score in MASLD Patients

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Tanta University 385
Post-approval studies (Phase 4)Active Not RecruitingNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Next Page